Great to see #ENZAp open at @SVHSydney and Austin Health! An Australian randomised combination Lu PSMA trial pre chemo in mCRPC. Thanks to ANZUP NHMRC CTC #ARTnet #ProstateCancerResearchAlliance Movember Australia ANSTO @adacap_news Astellas Pharma US

Great work team. First prospective combination LuPSMA trial demonstrating safety and efficacy in end stage mCRPC. ONCODOC @SVHSydney Noxopharm Limited @adacap_news Garvan Institute of Medical Research Sarennya Pathmananda

First patients injected with Ac225-PSMA-617 on the phase I AcTION trial at @SVHSydney today. Great to be joining sathegke mike at #Steve Biko Hospital in this trial. Thanks to #Alfred Morgenstern, ONCODOC M Crumbaker and our amazing radiochemists, MRS and trials team.